Approval · Notice of Compliance 4103 · 1997
DEPROIC: Notice of Compliance 4103
Issued June 16, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4103
- Date
- June 16, 1997
- Company
- Technilab Pharma Inc.Mirabel, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Anticonvulsant
- Canadian reference product
- DEPAKENE (Abbott Laboratories Co.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DEPROIC | 02231489 | Cancelled Post Market |
Medicinal ingredients
- VALPROIC ACID 500 MG per CAP